Table 1

Characteristics of patients with HIT in pre-intervention and avoid-heparin phases

CharacteristicPre-intervention phase, 2003-2005 (n = 53) No. (%)*Avoid-heparin phase, 2007-2012 (n = 26) No. (%)*P
Median age, years (IQR) 68 (60-74) 72 (61-78) .280 
Female 30 (57) 10 (38) .130 
Primary admitting service   .950 
 Cardiovascular surgery 32 (60) 15 (58)  
 Other surgical service 13 (24) 6 (23)  
 Cardiology 4 (8) 2 (8)  
 Medicine 4 (8) 3 (11)  
Median duration of UFH or LMWH exposure before the diagnosis of HIT, days (IQR) 10 (8-12) 11 (8-13) .526 
Median HIT ELISA OD (IQR) 2.07 (1.21-2.40) 2.79 (1.76-2.89) .001 
HIT ELISA OD   .123 
 <1.0 11 
 1.0-2.0 15 
 >2.0 27 18 
Median total length of stay, days (IQR) 24 (17-42) 21 (14-28) .224 
Median length of stay after HIT suspected, days (IQR) 14 (7-26) 9 (6-20) .198 
CharacteristicPre-intervention phase, 2003-2005 (n = 53) No. (%)*Avoid-heparin phase, 2007-2012 (n = 26) No. (%)*P
Median age, years (IQR) 68 (60-74) 72 (61-78) .280 
Female 30 (57) 10 (38) .130 
Primary admitting service   .950 
 Cardiovascular surgery 32 (60) 15 (58)  
 Other surgical service 13 (24) 6 (23)  
 Cardiology 4 (8) 2 (8)  
 Medicine 4 (8) 3 (11)  
Median duration of UFH or LMWH exposure before the diagnosis of HIT, days (IQR) 10 (8-12) 11 (8-13) .526 
Median HIT ELISA OD (IQR) 2.07 (1.21-2.40) 2.79 (1.76-2.89) .001 
HIT ELISA OD   .123 
 <1.0 11 
 1.0-2.0 15 
 >2.0 27 18 
Median total length of stay, days (IQR) 24 (17-42) 21 (14-28) .224 
Median length of stay after HIT suspected, days (IQR) 14 (7-26) 9 (6-20) .198 
*

Values are No. (%) unless otherwise indicated.

Date of admission to date of discharge.

Date HIT was first suspected to date of discharge.

or Create an Account

Close Modal
Close Modal